HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changyoun Kim Selected Research

Alzheimer Disease (Alzheimer's Disease)

1/2020Role of Alterations in Protein Kinase p38γ in the Pathogenesis of the Synaptic Pathology in Dementia With Lewy Bodies and α-Synuclein Transgenic Models.
1/2019Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like model.
1/2019Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Changyoun Kim Research Topics

Disease

24Parkinson Disease (Parkinson's Disease)
10/2023 - 10/2008
15Dementia (Dementias)
10/2023 - 07/2010
14Synucleinopathies
01/2023 - 10/2015
11Neuroinflammatory Diseases
04/2024 - 07/2010
11Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 07/2010
6Multiple System Atrophy
10/2020 - 07/2010
4Lewy Body Disease (Lewy Body Dementia)
01/2024 - 03/2016
4Nervous System Diseases (Neurological Disorders)
01/2021 - 03/2016
3Gliosis
04/2024 - 12/2015
3Alzheimer Disease (Alzheimer's Disease)
01/2020 - 01/2019
2Parkinsonian Disorders (Parkinsonism)
08/2017 - 03/2016
1Brain Diseases (Brain Disorder)
04/2024
1Inflammation (Inflammations)
01/2022
1COVID-19
01/2022
1Atrophy
01/2018
1Neurocognitive Disorders (Clerambault Syndrome)
01/2016
1Proteostasis Deficiencies
01/2016
1Neoplasms (Cancer)
12/2015
1Rheumatoid Arthritis
11/2009

Drug/Important Bio-Agent (IBA)

25SynucleinsIBA
04/2024 - 07/2010
9Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2010
4Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2016
4Toll-Like Receptor 2IBA
01/2021 - 10/2015
3CytokinesIBA
04/2024 - 12/2015
3Peptides (Polypeptides)IBA
01/2024 - 01/2019
3alpha-SynucleinIBA
01/2023 - 10/2008
2Small Interfering RNA (siRNA)IBA
01/2024 - 01/2019
2IronIBA
05/2022 - 12/2021
2Transferrin (beta 2 Transferrin)IBA
05/2022 - 12/2021
2VaccinesIBA
01/2022 - 01/2018
2Protein AggregatesIBA
01/2022 - 01/2020
2Phosphotransferases (Kinase)IBA
12/2021 - 01/2018
1Glycoproteins (Glycoprotein)IBA
04/2024
1Quinic Acid (Quinate)IBA
04/2024
1p38 Mitogen-Activated Protein KinasesIBA
10/2023
1Protein Isoforms (Isoforms)IBA
10/2023
1Neuroprotective AgentsIBA
01/2023
1NicotineFDA Link
01/2023
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2023
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
01/2022
1Leucine (L-Leucine)FDA Link
12/2021
1Protein Kinases (Protein Kinase)IBA
01/2020
1DNA-Binding Proteins (DNA Binding Protein)IBA
01/2020
1Amyloid beta-PeptidesIBA
01/2020
1OligonucleotidesIBA
01/2019
1Sirolimus (Rapamycin)FDA Link
01/2018
1AntigensIBA
01/2018
1Combined VaccinesIBA
01/2018
1GlucansIBA
01/2018
1AntibodiesIBA
08/2017
1Endosomal Sorting Complexes Required for TransportIBA
03/2016
1LipopolysaccharidesIBA
01/2016
1Glucosylceramidase (Glucocerebrosidase)IBA
01/2016
1EndotoxinsIBA
01/2016
1Amyloidogenic ProteinsIBA
01/2016
1hypoestoxideIBA
12/2015
1ApigeninIBA
11/2009
1FlavonoidsIBA
11/2009

Therapy/Procedure

6Immunotherapy
04/2024 - 08/2017
2Therapeutics
01/2022 - 01/2016
1Injections
01/2019